<DOC>
	<DOCNO>NCT02784847</DOCNO>
	<brief_summary>A pilot trial triheptanoin , natural compound able promote anaplerotic mitochondrial metabolism , preventative treatment migraine .</brief_summary>
	<brief_title>A Pilot Trial Triheptanoin Preventive Treatment Migraine</brief_title>
	<detailed_description>To test ability daily 3-month treatment triheptanoin prevent migraine attack 10 migraine patient . This open , non-randomized pilot trial might justify placebo-controlled trial , least 50 % patient â‰¥50 % reduction attack frequency .</detailed_description>
	<mesh_term>Migraine Disorders</mesh_term>
	<criteria>Females age 1865 year old effective contraception menopaused Diagnosis migraine without aura ( ICHD3beta 1.1 ) since least 2 year 410 migraine day per month last 3 month No preventive antimigraine therapy last month &gt; 4 tensiontype headache episode per month Medication overuse headache headache type Resistance &gt; 3 previous preventive antimigraine drug treatment Any serious medical psychiatric condition Ongoing previous bowel disorder</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>